Ali, Youssif Mohammed <br/><br/>
Low-dose recombinant properdin provides substantial protection against Streptococcus pneumoniae and Neisseria meningitidis infection.  [electronic resource] 

 -  Proceedings of the National Academy of Sciences of the United States of America  Apr 2014 
 - 5301-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1091-6490 
<br/><br/><label>Standard No.: </label>10.1073/pnas.1401011111  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Bacterial Vaccines--administration & dosage<br/>Dose-Response Relationship, Drug<br/>Meningococcal Infections--microbiology<br/>Mice<br/>Mice, Inbred C57BL<br/>Neisseria meningitidis--isolation & purification<br/>Pneumococcal Infections--prevention & control<br/>Properdin--pharmacology<br/>Recombinant Proteins--pharmacology